Dance and Movement Therapy in Patients With Schizophrenia (DMTinSchizo)

The Effect of Dance and Movement Therapy as a Group Work Technique on Negative Symptoms and Disability in Patients With Schizophrenia

Introduction: Schizophrenia is a mental disorder that starts at a young age and progresses with positive (hallucination, delusion) and negative (decreased emotional participation, reluctance) symptoms. While drug therapy in schizophrenia targets positive symptoms; psychotherapies are needed in the treatment of negative symptoms. It is seen that especially art therapies such as occupational and music support recovery and rehabilitation. In addition, it is stated that dance and movement therapy is effective in ensuring social participation of patients. There are a limited number of studies demonstrating the effect of dance and movement therapy on schizophrenia patients.

Aim: This project was planned to examine the effects of dance and movement therapy techniques to be applied to patients with schizophrenia on patients' negative symptoms and disability.

Method: In this project, which was planned in a repetitive measure design with a pretest-posttest control group, dance and movement therapy techniques, consisting of 12 sessions in total, will be applied to schizophrenic patients in a Community Mental Health Center once a week. Negative symptoms and disability levels will be determined before, after and a month after the application. The findings obtained as a result of these three follow-ups will be evaluated.

Project Outputs: Reduction of negative symptoms and disability will enable schizophrenic patients to become individuals who can express themselves better in their family and society and have an increased quality of life. It is thought that these gains will increase patients' compliance with treatment, prevent recurrent symptoms and reduce hospitalizations. The results will also constitute a scientific source for the studies to be carried out in the field.

Study Overview

• Status: Completed
• Conditions: Schizophrenia; Disabilities Mental; Negative Symptoms in Schizophrenia; Dance Therapy
• Intervention / Treatment: Other: Dance and Movement Therapy (DMT)

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Gonca Ustun, PhD; Phone Number: +905388589647; Email: gonca_ustun@hotmail.com

Study Locations

• Turkey
  • Amasya, Turkey
    • Amasya Üniversitesi Sabuncuoğlu Şerefeddin Eğitim Ve Araştirma Hastanesi

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• have been diagnosed with schizophrenia for at least two years
• not have been hospitalized in the past 3 months

Exclusion Criteria:

• have a therapy/psychoeducation program that they attend regularly
• have a known physical or neurological disease
• having just started the Community Mental Health Center

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control group
Experimental: Experimental group; Dance and movement therapy is planned to be applied once a week as a total of 12 sessions of 60 minutes. First session; meeting, warming up, determining the group rules, explaining the principles, determining the expectations activities. Subsequent sessions; The greeting is completed with warm-up, initiation, continuation and closing activities. During the warm-up phase, the whole group comes together to form a circle, generally standing, in order to ensure the group dynamic. It starts with simple warm-up exercises such as breathing and muscle relaxation and continues with body awareness exercises. In the continuation (development of themes) stage, practices are included according to the characteristics and needs of the group.	Other: Dance and Movement Therapy (DMT); Dance and movement therapy is planned to be applied once a week as a total of 12 sessions of 60 minutes. First session; meeting, warming up, determining the group rules, explaining the principles, determining the expectations activities. Subsequent sessions; The greeting is completed with warm-up, initiation, continuation and closing activities. During the warm-up phase, the whole group comes together to form a circle, generally standing, in order to ensure the group dynamic. It starts with simple warm-up exercises such as breathing and muscle relaxation and continues with body awareness exercises. In the continuation (development of themes) stage, practices are included according to the characteristics and needs of the group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The Scale for the Assessment of Negative Symptoms (SANS)	Scale; It consists of five parts, including flattening or blunting in affect, alogy, decreased energy and desire, lack of pleasure and social withdrawal, attention, and a total of 24 items. Scale items 0=none; 1=doubtful; 2=light; 3=medium; 4=pronounced; It is scored as 5=severe. The negative symptoms rating scale is a type of scale that the interviewer evaluates. The filling of the scale is based on the interview with the patient, the observations during the interview and the information received from the people around the patient. Cronbach's alpha for the whole scale is 0.94. Values that can be taken from the Scale for the Assessment of Negative Symptoms (SANS); minimum=0, maximum=120 points. It shows that as the score increases, the severity of negative symptoms increases.	6 months
Disability Evaluation Schedule (WHO-DAS-II)	Disability Assessment Chart is a 36-item scale. This tool tries to determine how much difficulty an individual with schizophrenia has while performing certain activities and consists of 6 areas that include activities that are considered important in many cultures. These are grouped under the headings of understanding and communicating, moving and moving from place to place, self-care, human relations, life activities, participation in social life. In questions about all these areas, it is asked how much difficulty the person has had during that activity in the last month, and the answers received as not at all, mild, moderate, very much, excessively/not at all are scored between 1-5. It is applied by the interviewer in approximately 20 minutes. Cronbach's alpha for the whole scale is 0.92. Values that can be taken from the Disability Evaluation Schedule (WHO-DAS-II); minimum=0, maximum=100 points. It shows that as the score increases, the severity of disability increases.	6 months

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Personal Information Form	The questionnaire form prepared by the project team consists of 10 questions in total, including the socio-demographic characteristics (age, gender, marital status, education level, employment status, income level, cohabitants) of the patients and their disease-related characteristics (age of onset of disease, duration of disease (years), number of hospitalizations).	2 weeks

Collaborators and Investigators

• Sponsor: Amasya University

Study record dates

Study Major Dates

• Study Start (Actual): September 1, 2022
• Primary Completion (Actual): December 6, 2022
• Study Completion (Actual): February 15, 2023

Study Registration Dates

• First Submitted: August 10, 2022
• First Submitted That Met QC Criteria: August 11, 2022
• First Posted (Actual): August 15, 2022

Study Record Updates

• Last Update Posted (Actual): May 23, 2023
• Last Update Submitted That Met QC Criteria: May 21, 2023
• Last Verified: May 1, 2023

More Information

Terms related to this study

• Keywords: Dance and movement therapy
• Additional Relevant MeSH Terms: Mental Disorders; Schizophrenia Spectrum and Other Psychotic Disorders; Schizophrenia
• Other Study ID Numbers: AmasyaU8

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No